22.07.2011Call of papers for NanoBiotech MontreuxYou are hereNewsCall of papers for NanoBiotech Montreux
NanoTech Montreux is a unique Conference at the frontiers of both Micro- and Nano- technologies, with a special emphasis on Biological, Chemical and Medical applications.
The format includes plenary talks from invited speakers of international renown, giving lectures on significant aspects of the scope, together with a variety of short oral presentations of original new research.
Participants from over 15 countries encompassing Europe, America and Asia meet in a relaxed and informal atmosphere, ideal for the creative exchange of ideas and the development of new collaborative projects.
The Exhibition gives the opportunity to present the latest developments in nano- and microtechnologies to an informed and active audience.
In addition to exhibiting, we are also offering each exhibitor the possibility of participating in “snapshot” presentations during the plenary session.
Call for papers
• World leading plenary speakers
• State-of-the-art science and discussion that makes a difference
• Cutting-edge work from students in posters and flash presentations
• A highly focused meeting lasting only 2.5 days, single track oral sessions
• Prizes and awards for student's posters
• A beautiful, relaxed and idyllic setting on the edge of Lake Geneva
• Conveniently timed and located in Montreux since 1996
Deadline for abstract submission: Oral: (extended to) July 30 Poster: Sept. 15
Voisin Consulting CH, SàrlProfessional Services & Consulting, Business Development Services
Professional Services & Consulting, Consulting (Drug development, due diligence, deal)
Professional Services & Consulting, Quality
Professional Services & Consulting, Regulatory & Clinical Services
Voisin Consulting Life Sciences guides Biotechnology, Pharmaceutical and Medtech manufacturers throughout product development and commercialization. VCLS assists innovators to design product development strategies that optimize clinical development in order to drive commercial success, through an understanding of both regulators and payers. VCLS team understands our clients’ science and business objectives and seamlessly supplements their own resources with strategic advice and operational capabilities.
Identify and manage product-related risks
Anticipate and address challenges along health products life cycle
Communicate with regulators and payers
Translate Quality, Safety, Efficacy and Cost-Effectiveness into Value
From discovery to patients, our team of healthtech product specialists offers integrated solutions to development planning, manufacturing, quality and control, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers.
With offices in Cambridge (MA, USA), Paris and Rennes (France), London (UK), Lausanne (Switzerland) and Bangalore (India), VCLS serves a broad range of developers and investors.